IMRIS to hold first quarter 2014 results conference call and 2014 annual meeting of shareholders
PR Newswire - Thu May 08, 10:00AM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
Nasdaq stocks posting largest volume increases
AP - Thu Apr 24, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Tampa General Hospital launches advanced intraoperative MRI use with first cases
PR Newswire - Thu Apr 24, 7:00AM CDT
IMRIS VISIUS iMRI improves surgical results and patient outcomes for neurosurgery
Neurosurgery journal published study reinforces value of high-field iMRI
CNW Group - Thu Apr 17, 7:00AM CDT
VISIUS intraoperative MRI significantly enhances amount of complete resection in brain tumors and leads to better patient outcomes
5 Stocks Under $10 Set to Soar
at The Street - Thu Apr 03, 1:08PM CDT
These under-$10 stocks look ready to trade higher from current levels.
IMRIS sponsoring Practical Clinic and exhibiting intraoperative MR and CT imaging techniques at AANS
PR Newswire - Tue Apr 01, 7:00AM CDT
Solutions provide on-demand access to state-of-the-art imaging during procedures
IMRIS pediatric horseshoe headrest enables iMRI for even the youngest neurosurgery patients
CNW Group - Wed Mar 26, 6:31AM CDT
Le Bonheur neurosurgeons complete first cases using MR-safe headrest designed specifically for intraoperative imaging in VISIUS Surgical Theatre
Magnetic Resonance Imaging (MRI) System Advances Market Forecasts & Opportunities, 2018
M2 - Tue Mar 25, 10:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dgsl45/advances_in) has announced the addition of the "Magnetic Resonance Imaging (MRI) System Advances Market Forecasts & Opportunities, 2018" report to their offering. The global market for these systems values $4.13 billion, as of the first quarter of 2013, and is expected to grow at a CAGR of 4.56% reaching approximately around $5.24 billion by 2018 The current magnetic resonance imaging industry is producing over 2,000 units per year. . As of March 2013, North America dominates the market with nearly 40% share, followed by Europe due to technological developments for effective diagnostics and rapidly aging population. However, Asia is slated to grow at a high CAGR of 5.2% over the analysis period. Improved spending capability and physicians inclination towards MR imaging over other conventional medical imaging modalities is fuelling demand for MRI across this region. Asia holds enormous growth potential, particularly from countries with large population base such as China and India. The demand is anticipated primarily from private hospitals compared to public hospitals. The adoption of MR imaging equipment market is also likely to grow owing to the rising incidences of cardiac diseases, neurological and oncological cases in the region. Liquid helium, which has an extremely low boiling point of minus 452.07?F, is used for cooling the superconducting magnets of MR systems. A severe shortage in the availability of helium across the globe would affect significantly for MR OEMs. The prices for hospital-grade helium are anticipated to rise from 2013, leading to higher health-care costs or, in the worst scenario, the need for an alternative technique for cooling MRI machines. Moreover, changing healthcare reforms from early 2013 in the U.S. also resulted in 20-25% reimbursement cuts for MRI, affecting the global clinical OEMS, physicians and healthcare payers. Nevertheless, once market barriers of tight R&D budgets, high costs of MRI scans and alternate cooling systems are resolved, the industry is expected to grow considerably. With technology developers exploring many new applications, especially those involving cardiac and breast imaging, it was inevitable that magnetic resonance imaging would evolve into a highly sophisticated medical imaging tool. Scope of the Report Architecture - Closed systems - Open systems Field Strength - Low field strength systems - Mid field strength systems - High field strength systems Technology - MR Angiogram - MR Venogram - Functional MRI - MR Spectroscopy - Others -Fusion MR Application - Whole Body MRI systems - Interventional MRI systems - MRI for Brain and Neurological disorder - Breast MRI systems - Cardiac MRI systems - MR systems for Other applications such as -;Chest,Neck, Upper and Lower extremities Companies Mentioned - Advanced Imaging Research, Inc. Dba Sree Medical Systems - Agilent Technologies, Inc. - Asg Superconductors S.P.A. - Aurora Imaging Technology - Bartington Instruments, Ltd. - Bayer Healthcare Pharmaceuticals - Biophan Technologies, Inc. - Bruker Biospin Gmbh - Doty Scientific, Inc. - Esaote S.P.A - Fonar Corporation - Ge Healthcare - Hitachi Medical Corporation - Imris, Inc. - Insightec Ltd. - Lmt Lammers Medical Technology Gmbh - Mr Instruments, Inc. - Philips Healthcare - Shenzhen Basda Medical Apparatus Co. Ltd. - Siemens Healthcare - Time Medical Systems - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/dg...dvances_in
IMRIS delivers first unequaled imaging technology into the operating room during brain surgery
M2 - Wed Mar 19, 8:38AM CDT
Image therapy company IMRIS (NASDAQ:IMRS)(TSX:IM) stated on Wednesday that Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, NH, have completed several cases to inaugurate use of the former's intraoperative MRI (iMRI) within the VISIUS Surgical Theatre inside the hospital's Center for Surgical Innovation (CSI).
Dartmouth-Hitchcock Medical Center inaugurates unique intraoperative MRI and CT suite with initial brain tumor procedures in Center for Surgical Innovation
CNW Group - Wed Mar 19, 6:30AM CDT
VISIUS iMRI and iCT expected to expand surgical vision and precision and further research
IMRIS (IMRS) Research Report Issued By WealthMakers.com
M2 - Wed Mar 12, 11:23AM CDT
March 12, 2014 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on IMRIS (NASDAQ: IMRS). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $3.75 and the projected fundamental valuation of $4.14.
IMRIS (IMRS) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 8:54AM CDT
IMRIS (IMRS) Enters Oversold Territory
IMRIS reports 2013 fourth quarter and full-year financial results
PR Newswire - Tue Mar 04, 3:00PM CST
-- Company completes transition year and lays foundation for profitable growth;